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Background: Operative mortality after complete atrioventricular septal defect (cAVSD) repair 
has improved vastly. Less improvement has been demonstrated regarding late mortality and 
reoperation rates. There is evident lack of comprehensive population-based studies 
analyzing the history and progress of the ever-changing operative results.  
Methods: This is a 5-million population-based retrospective study of consecutive 388 cAVSD 
patients operated in Finland between 1962 and 2014. Data was collected using Children’s 
Cardiac Surgical Registry of Children’s Hospital at the Helsinki University Hospital, Finland. 
Mortality data and reoperation rates were analyzed on a decade-by-decade basis. 
Results: During the early era, overall mortality was 17.4%, operative mortality comprising 
10.9%. The operative results have improved significantly over the decades, and eventually, 
the last decade showed no mortality. Total of 23 late deaths occurred; of these, 20 were 
directly heart-related. Half of the late mortality occurred during the first postoperative year. 
The only significant risk factor for overall mortality was an earlier decade of operation 
(p<0.001). Reoperation rates have not decreased but slightly increased over decades 
(p=0.621), and reoperations have been performed mainly during the first year after the 
primary operation. Actuarial freedom from left side AV valve reoperation at 15 years was 
90,9%.  
Conclusions: There has been an outstanding improvement in surgical results through years 
even though the general operative approach has remained the same. Rates of reoperation 
have not been declining, but the reoperations are dated to early childhood years. The 
improvement in results has been ongoing.  
 















cAVSD, complete atrioventricular septal defect 
LAVV, left atrioventricular valve 
SD, standard deviation 
ICU, intensive care unit 
PA, pulmonary artery 
CPB, cardiopulmonary bypass 
MI, mitral insufficiency 
PH, pulmonary hypertension 
CHF, congestive heart failure 
MS, mitral stenosis 
MOF, multi-organ failure 
NEC, necrotizing enterocolitis 
CI, cerebral infarction 
SVT, supraventricular tachycardia 














The early decades of complete atrioventricular septal defect (cAVSD) repair surgery 
were associated with high perioperative mortality after the first successful repair performed 
by C. Walton Lillehei and associates in the 1950’s. Later, significant improvements in 
perioperative and late mortality have been demonstrated (1, 2, 3, 4). The early and long-term 
results of cAVSD patients are readily connected to the technical achievement at the surgery 
and, in particular, achieved left atrioventricular valve (LAVV) function. However, at the same 
time, there is a steady improvement in early survival after cAVSD repair and a concomitant 
regularity or a slight increase in the need for recurrent left AV valve plasty (1). A complete 
population analysis of the operative results of cAVSD could thereby show the evolution of the 
of surgical treatment in a single center setting. 
The cardiac surgery patient registry of the Children’s Hospital at the Helsinki University 
Hospital in Finland is particularly comprehensive and includes all corrective cAVSD 
operations performed in Finland since the beginning of corrective surgery in the 1960s with 
comprehensive follow-up of all operated patients. Patients’ survival status has been 
crosschecked with Statistics Finland’s causes-of-death registry. Finnish health care system is 
based on a social welfare model which limits no treatments from personal funds or health 
insurance, which makes the treatments available to all in need. Thus, our study includes a 
nationwide cohort of patients and is the first of its kind to examine all reparative operations 
for cAVSD since the beginning of corrective surgery in a single nation. 
The purpose of this study was to determine the long-term outcome, atrioventricular 
valve reoperation rate, and risk factors of mortality and reoperation during the 50 years of 

















Patients and Methods  
Data collection 
Data were acquired using the surgical patient registry of the Children’s Hospital, 
Helsinki University Hospital, which includes all children’s heart operations performed since 
the beginning of pediatric cardiac surgery in Finland. The registry and the study protocol 
were approved by the local ethics review board at Helsinki University Hospital. A registry 
search was performed to identify all two-ventricle repairs for complete atrioventricular septal 
defect between 1962-2014. Patients with unbalanced ventricles, operated by a single 
ventricle line, were not included in this cohort. Criteria for the single ventricle palliation has 
been determined by left ventricular volume, inflow and outflow measurements according the 
standards of time being. Following variables were collected and analyzed to determine 
possible preoperative and perioperative risk factors for mortality and need for reoperation: 
trisomy-21, age at operation, gender, concurrent cardiac anomalies, the decade of procedure 
and perioperative complications. 
Late survival data were acquired using the Central Population Register of Finland with 
patients’ social security number. This register includes mortality data on all Finnish nationals. 
Death certificate data were acquired for those who had died during the follow-up period. 
Other methods of data collection were questionnaires sent to patients during the follow-up 
period at a few years’ intervals and medical history records sent us by the patients’ attending 
physicians. In the end, three patients (0.7%) of the primary study cohort were excluded from 
the analysis, all of them because of emigration and thus failure to acquire late survival data. 
Mean follow-up for all patients was 11.6 years (median 10.6, range 0-40.5). Mean follow-up 
for all hospital survivors was 13.0 years (median 12.0, range 0.1-40.5). 
Study Endpoints 
Primary outcomes for this study included survival and need for LAVV-related 
reoperation after initial two-ventricle complete AVSD repair. Mortality was further classified 














postoperative period). For the causes of late death analysis, late deaths were further 
categorized into two groups. One was those patients who suffered mortality between 30 days 
and one year after primary repair and the other for those who died more than one year after 
primary repair. Reoperation was defined as any corrective surgery of the LAVV after the 
initial repair for the complete atrioventricular septal defect. The indication of LAVV 
reoperation was significant residual insufficiency leading to enlargement of the left ventricle 
and left atrium of more than +2 standard deviations (SD), with or without symptoms including 
arrhythmias. Criteria for the single ventricle palliation has been determined by left ventricular 
volume, inflow and outflow measurements according to the standards of time being.  
Statistical Analysis 
Continuous variables are reported as mean and median with range. Categorical 
variables are reported as frequencies and percentages of the total.  Risk factors for mortality 
and need for reoperation were assessed using the binary logistic regression analysis. 
Actuarial survival and freedom from reoperation were estimated using the Kaplan-Meier 
method and groups were compared using the Mantel-Cox (log-rank) test when needed. 
Decade by decade trends for hospital and intensive care unit (ICU) length-of-stay were 
analyzed using one-way ANOVA. Levene’s test for homogeneity of variances was used to 
assess equality of variances. Post hoc testing was performed using the Tukey’s HSD test. 
Statistical significance was assumed with a p-value lower than 0.05. 
Data were analyzed using IBM SPSS Statistics, version 23 (International Business 




















We identified a total of 388 patients who underwent a biventricular repair for complete 
atrioventricular septal defect between 1962-2014. Patient characteristics are summarized by 
a decade of operation in Table 1. The overall study cohort included 228 female (58.8%) and 
160 male (41.2%) patients of whom 285 (73.3%) had trisomy 21 (Down’s syndrome). 
Patients with Down’s syndrome were not operated before the1980s. The median age at the 
time of operation decreased decade by decade from 14.5 years in the 1960s to 0.32 years in 
the 2000s (range 0.2-2.7 years).  
Associated cardiac anomalies included ventricular septal defect in 13 patients (3.4%), 
coarctation of the aorta in 15 patients (3.9%), claimed patent ductus arteriosus in 64 patients 
(17.5%; yet routine ligation of the ductus arteriosus is the norm), double-outlet right ventricle 
in 2 patients (0.5%), pulmonary valve stenosis in 9 patients (2.3%), total anomalous 
pulmonary venous connection in 1 patient (0.3%) and tetralogy of Fallot in 15 patients 
(3.9%). Eight patients had exposed to previous cardiac operations before cAVSD repair. Six 
of these patients had had a prior corrective cardiac surgery for coarctation of the aorta, 2 of 
these patients for patent ductus arteriosus. Seventeen patients (4.4%) had undergone prior 
palliation with pulmonary artery banding, primarily in the 1980s. As a surgical method, the 
two-patch technique was used almost uniformly since the early 1980s. 
Overall mortality 
During the follow-up period, a total of 67 patients (17.4%) died. Of these, there were 42 
operative deaths (62.7% of all deaths) and 25 late deaths (37.3%). Overall mortality showed 
improvements decade by decade. This improvement is illustrated in Table 2. No operative 
deaths have occurred after the year 2002.  
The actuarial survival for all patients (n=388) was 85.8% (+/- 1.8%) at 1 year, 84.3% 














actuarial survival by a decade of operation using a Kaplan-Meier method the mortality was 
decreasing every decade. This finding was statistically significant (p<0.001). The results are 
illustrated in Figure 1. 
Predictors of overall mortality 
We analyzed obtained patient variables for the risk of total mortality using univariate 
binary logistic regression analysis. Only the decade of operation showed a statistically 
significant effect on all mortality. Down’s syndrome and higher age at operation showed a 
trend towards lower risk of mortality, although the difference was not statistically significant 
(p=0.122 and p=0.121 respectively). Pulmonary artery (PA) banding was associated with a 
tendency towards higher risk of death, but the difference lacked statistical significance 
(p=0.145). Patients sex and required reoperation had no association with postoperative 
mortality (p>0.05). 
In the multivariate binary logistic regression analysis for the mortality risk, based on the 
potential risk factors in the univariate analysis, only the decade of operation showed 
statistical significance with an odds ratio (OR) of 0.34 (0.23-0.49, p<0.001). Results of the 
logistic regression analysis are presented in Table 3. 
Causes of late mortality 
A total of 23 late deaths occurred during the follow-up. Actuarial survival was analyzed 
with a Kaplan-Meier analysis. Differences between the decades of operation were not 
statistically significant (p=0.328). About half of the late deaths (11 of 23, 47.8%) occurred 
during the first postoperative year. As shown in Figure 2, all except three late deaths were 
due to either a cardiac cause or an infection. Sixteen of the deaths were cardiac related 
(69,6%), four were due to infectious causes (17.4%). One patient suffered a late death due to 
cerebral infarction after surgery for scoliosis (4.3%). For the remaining two, the cause of 















After the initial biventricular repair of the complete AVSD, a total of 31 reoperations, 
were performed on 29 patients. Ten (32.2%) of these were early reoperations during the first 
30-day postoperative period. 
Twenty-nine patients (7.5%) had reoperation because of atrioventricular valve 
insufficiency, two of these patients needed more than one reoperation (one patient with 
secondary AV-valvuloplasty and one patient with secondary AV-valve prosthesis). Five of 
these patients had a concurrent residual ventricular septal defect which was corrected on the 
same session. 
In addition to these LAVV reoperations 15 other reoperations were performed on 15 
patients. A total of 13 patients needed a permanent cardiac pacemaker. One patient was 
reoperated for right ventricular outflow tract restenosis, and one patient was reoperated for 
subvalvular aortic stenosis.  
Actuarial freedom from LAVV-related reoperation was assessed using the Kaplan-
Meier method. Kaplan-Meier estimates for freedom from reoperation were 94.8% (+- 1.2%) 
at 1 year, 92.9% (+/- 1.4%) at 5 years and 90.9% (+/- 1.6%) at 15 years. Decade by decade 
Kaplan-Meier analysis among all patients did not reveal any statistically significant difference 
in reoperation rates through the decades (p=0.621, Figure 3). 
Predictors of the need for reoperation 
We tested different variables for the risk of the need for reoperation using univariate 
binary logistic regression analysis. No statistically significant risk factors were identified. No 
patients with a prior PA banding had been reoperated, and thus we excluded the previous 
PA banding variable from the analysis.  
A multivariate logistic regression analysis was performed with the most promising 
patient variables in the model. No statistically significant risk factors were identified. Results 














Freedom from reoperation and death combined 
Because there seemed to be a trend towards increasing reoperation rate (and thus it 
might be that some patients in need of reoperation died instead of reoperation), data about 
survival and need for reoperation were combined and analyzed same as above. 
During the follow-up, 92 patients (23.7%) died or underwent reoperation for AV 
regurgitation, four of whom belonged to both categories (died after reoperation). The 
actuarial freedom from reoperation and death was 82.0% (+/- 2.0%) at one year, 79.1% (+/- 
2.1%) at 5 years and 76.0% (+/- 2.3%) at 15 years of follow-up for the whole cohort. When 
we compared the results by a decade of operation using the Kaplan-Meier method, there 
was a statistically significant (Figure 4) trend towards better results every decade. 
Predictors of the need for reoperation and death combined 
We used binary logistic regression to analyze possible risk factors for the combined 
endpoint. Only the later decade of operation was a statistically significant protective factor 
against reoperation and death with a per decade OR of 0.52 (0.39-0.68, p<0.001). Results of 
the analysis are presented in Table 5. Associated anomalies did not show predictive value, 
probably due to the low incidence.  
Hospitalization 
Length-of-stays at the ICU and in the hospital were acquired. Time at the ICU could be 
obtained for all except 15 patients. Median of ICU stay was six days (0-59, mean 6.8). 
Median of ICU stay for those who survived the hospital was six days (0-59, mean 6.7). There 
was a statistically significant difference in the length of ICU stay when we compared the 
length of stay decade by decade (One-way ANOVA, F=3.484, p=0.004). Post hoc testing 
showed a decreasing trend in length of ICU stay in a decade by decade analysis. 
Length of hospital stay data could not be acquired on 67 patients, mainly from the early 














those who survived the hospital was 12 days (5-71, mean 14.5). There was a statistically 
significant difference in the length of hospital stay when we compared the length of stay 
decade by decade (One-way ANOVA, F=2.786, p=0.018). Post hoc testing showed a 
decreasing trend in the length of hospital stay in a decade by decade analysis. 
 
Comment  
This study is a 5-million population-based analysis of the results of cAVSD repair in 
Finland during the whole surgical treatment era of more than 50 years. With 99.3% follow-up 
coverage of operated patients, this study features particular comprehensiveness of a 
nationwide cohort of 388 consecutive patients. Operative mortality showed a steadily 
decreasing trend when assessed decade by decade, a finding still evident in the latest 
decades. No operative deaths have occurred since 2002. However, the improvement in late 
mortality has been less apparent. 
Previous data show a significant improvement in both early and late results among 
pediatric cardiac surgery patients (4). This has also been acknowledged in AVSD patients, 
which is especially interesting since the operative approach has been practically unchanged, 
i.e., shunt closure with mainly two-patch technique with the closure of the LAVV cleft 
whenever possible. A widespread reduction in operative mortality is observable in analyses 
done using the extensive North American STS database (5,6,7), and similar results have 
been shown in single centers (1-3,8).  
The decrease in operative mortality represents an improvement in perioperative care 
as well as a change in patient characteristics. Risk factors for operative death include 
pulmonary hypertensive crises (10) and severe LAVV regurgitation in the immediate 
postoperative period (3, 10). In this long-term study, factors contributing to the improvement 
in operative mortality might be the advances in intensive care and perfusion techniques. New 














inhaled nitrous oxide in 1993 and milrinone in 1998, amrinone a few years earlier. 
Additionally, availability of around-the-clock children’s cardiac anesthesiologist in the 
pediatric ICU since the end of the 1990s has improved postoperative care at our institution. 
During the 1990s increasing operation frequency brought surgical refinements and 
standardization. At that time, institutional learning must have improved all levels of treatment. 
Most importantly, the age at the time of complete repair has decreased and – at present – 
repair is performed at the median age of about 0.32 years (under four months) at our 
institution. This might be the major factor contributing to the decrease in operative mortality: 
the earlier repair prevents the development of permanent changes in the pulmonary 
vasculature and thus reduces the risk for pulmonary hypertensive crises previously shown to 
be a risk factor for operative mortality. We have kept the operative age on the late side of the 
spectrum with an idea to gain more tissue strength at the operation. 
The improvement in late survival has been subtler. In our cohort, about half of the late 
deaths occurred during the first postoperative year. Late death among those patients who 
survive the first postoperative year is uncommon in the scope of our follow-up period. We 
could see a small improvement in late survival when we compared the results decade by 
decade. In our material, late deaths are almost uniformly cardiac of origin with usually a 
complicating infection causing the acute worsening. It can be argued that these deaths could 
be prevented be it that cardiac condition was treated more aggressively.  
The late survival goes hand in hand with LAVV function: the main factor affecting the 
late mortality is LAVV regurgitation (2, 9). As Crawford (1) concluded in the analysis of his 
personally operated 20-year cohort, the late incidence of LAVV-related reoperation seems to 
have stayed constant. Our data support the studies implying (1) that there has been little 
improvement regarding the need for LAVV reoperation decade by decade, as the rates for 
reoperation due to LAVV incompetence have stayed around 10% at ten years for the last 
decades, and we saw a small but statistically insignificant trend towards increasing 














valve tissues and smaller dimensions. This may contribute to unsatisfactory surgical results, 
which might eventually partly explain the remaining need for early reoperations. As 
previously proposed (1), the risk for reoperation seems to be highest in the early 
postoperative period with no reoperations performed after more than a 9-year follow-up after 
the initial repair in our patient material. The mean time for LAVV-related reoperation was at 
1.79 years of follow-up after primary repair (median 0.53 years). As shown above, the 
insufficiency of the LAVV could most commonly be managed with a repair of the LAVV rather 
than valve replacement, which is in line with previous research (2).  
We analyzed the combined end-point of freedom from LAVV reoperation and overall 
mortality and saw statistically significant stepwise improvement in results through the 
decades. The analysis showed that although there was a slightly increasing trend in the 
reoperations due to LAVV insufficiency through the decades, the overall results have still 
improved significantly. Our contemporary mortality and reoperation rates are in line with the 
previous single-center results (1-3, 8) and strengthen the fact that the results have improved 
considerably from the early days of corrective AVSD surgery.  
This study included a large nationwide cohort of patients with surgically corrected 
cAVSD with practically complete follow-up, but it has its limitations. Firstly, although we 
selected all patients with a two-ventricle repair, we cannot rule out the fact that there might 
have been some included patients with borderline ventricles as the retrospective design of 
this study does not allow us to collect all possibly relevant data. However, we have no 
conversions to the univentricular line, according to the reoperations data. Secondly, the 
analyses were only performed using hard clinical data on survival and reoperations, which 
might not reflect the differences in quality of life or functional status of the patients. The 
primary diagnostic studies at the time of repair were unavailable for all patients and therefore 
were not used in risk factor analysis. The registry was created in the late 1980s and thus 














number of different operating surgeons at one institution and might not take into account the 
possible  differences in operating techniques and care strategies used in other centers.   
In this study, we have shown the evolution in the treatment results of cAVSD patients in 
a true nationwide cohort of more than 50 years. There has been a tremendous change in the 
surgical results of cAVSD repair when the results are assessed decade by decade. The 
improvement has been stepwise and has been continuing even in the latest decades. Most 
of the mortality in the scope of our follow-up is LAVV-related and is observed in the early 
period after primary repair. The marked improvement in survival from the early era of 
hypothermic arrest without cardiopulmonary bypass is underlined by the fact that, in our 
series, the last perioperative death occurred in 2002. As we are now approaching better and 
better survival of the patients on each decade, morbidity studies are necessary to optimize 
the treatment protocols for patients with cAVSD. Nevertheless, according to our results, 
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 Table 1. Patient and operative characteristics by d ecade of operation 
 All 1960’s 1970’s 1980’s 1990’s 2000’s 2010’s 
n 388 1 12 60 149 120 46 














Down’s, n(%) 285 
(73.3%) 
0    
(0%) 







































































0    
(0%) 
Age, mean (yrs) 0.95 14.49* 4.04 1.70 0.90 0.43 0.43 
Age, median 
(yrs) 
0.40 14.49* 2.65 0.77 0.35 0.32 0.38 
Hospital stay, 
mean (d) 
14.05 5* 6.5* 16.4 * 16.0 12.5 11.8 
ICU stay, mean 
(d) 
















77.1 NA NA NA 74.4 78.2 77.3 
CPB (min) 115.4 NA NA NA 118.0 115.1 113.5 
 
ICU, intensive care unit; xclamp, cross-clamp; CPB, cardiopulmonary bypass: LAVV, left 
atrioventricular valve. 

















Table 2. Postoperative mortality by decade of opera tion 
 1960’s 1970’s 1980’s 1990’s 2000’s 2010’s 
All operated, n 1 12 60 149 119 45 
Operative 









4    
(3.3%) 
0 






12   
(8.3%) 
4    
(3.3%) 
0 








8    
(6.6%) 




























Table 3. Analysis of potential risk factors associa ted with postoperative mortality 
 Univariate model Multivariate model 
 OR (95% CI) p-value OR (95% CI) p-value 
Decade of operation 0.38       
(0.28-0.52) 
<0.001 0.34       
(0.23-0.49) 
<0.001 
Female sex 1.31       
(0.76-2.25) 
0.340   
Down’s syndrome 0.64       
(0.36-1.13) 
0.122 0.96       
(0.49-1.86) 
0.895 
Age at operation (per 
year) 
1.10       
(0.98-1.23) 
0.121 0.88       
(0.75-1.04) 
0.127 
Required reoperation 0.75       
(0.25-2.22) 
0.599   
Prior PA banding 2.25       
(0.76-6.71) 























Table 4. Analysis of potential risk factors associa ted with LAVV reoperation 
 Univariate model Multivariate model 
 OR (95% CI) p-value OR (95% CI) p-value 
Female sex 0.73 (0.34-1.57) 0.425 0.74 (0.34-1.58) 0.433 
Decade of operation 1.30 (0.88-1.93) 0.194 1.34 (0.91-1.98) 0.141 
Down’s syndrome 0.67 (0.30-1.50) 0.330 0.61 (0.27-1.37) 0.232 
Age at operation 
(per year) 

























Table 5. Analysis of potential risk factors associa ted with the combined end point 
 Univariate model Multivariate model 
 OR (95% CI) p-value OR (95% CI) p-value 
Down’s syndrome 0.69 (0.41-1.14) 0.146 0.89 (0.51-1.55) 0.670 
Female sex 1.12 (0.70-1.81) 0.638   
Decade of operation 0.53 (0.41-0.69) <0.001 0.52 (0.39-0.68) <0.001 
Age at operation (per 
year) 
1.08 (0.96-1.20) 0.194 0,95 (0.83-1.08) 0.410 























Figure 1. Kaplan-Meier estimates of actuarial survival by decade of operation. The mortality 
has decreased in a consistent manner when compared decade by decade. 
 
Figure 2. Kaplan-Meier estimates of actuarial late survival by decade of operation. Late 
survival has shown a decreasing, yet statistically insignificant trend through the decades. MI, 
mitral insufficiency, PH, pulmonary hypertension, CHF, congestive heart failure, MS, mitral 
stenosis, MOF, multi-organ failure, NEC, necrotizing enterocolitis, CI, cerebral infarction, 
SVT, supraventricular tachycardia, DCM, dilating cardiomyopathy. 
 
Figure 3.  Kaplan-Meier estimates of actuarial freedom from LAVV reoperation by decade of 
primary operation. Reoperation rate has shown a slightly increasing trend through the 
decades. This difference is not statistically significant. Reoperations are situated in the early 
postoperative period. 
 
Figure 4. Kaplan-Meier estimates of actuarial portion of patients alive and free from 
reoperation by decade of primary operation. The results have improved in a consistent 
manner when the end points have been combined. The latest decades show no difference. 
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